Physician profile
Mirtha A Gonzalez
NPI 1891026316
$2,586.48
in general payments reported to CMS, 2019-2025
23 companies · $512 in 2025
The $512 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $44.61 · 2021: $367 · 2022: $375 · 2023: $435 · 2024: $603 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,549.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $450.20 | 2019-2022 | |
| Abbvie INC. | $369.47 | 2023-2024 | |
| Revance Therapeutics, INC. | $295.80 | 2024-2025 | Daxxify |
| Lilly USA, LLC | $284.68 | 2022-2025 | Taltz, Ebglyss, Olumiant |
| Janssen Biotech, INC. | $211.79 | 2022-2025 | Tremfya |
| Vyne Pharmaceuticals INC. | $140.08 | 2021 | |
| Incyte Corporation | $102.71 | 2023-2025 | Opzelura |
| Ucb, INC. | $100.98 | 2021-2025 | Bimzelx |
| Merz North America, INC. | $98.92 | 2019-2022 | |
| Amgen INC. | $94.17 | 2021-2024 | Otezla |
| Almirall LLC | $61.30 | 2024-2025 | Klisyri, Seysara |
| Dermira, INC. | $49.92 | 2019 | |
| Cardiovascular Systems INC. | $48.76 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $46.78 | 2023-2025 | Cabtreo, Arazlo, Jublia |
| Novartis Pharmaceuticals Corporation | $43.27 | 2023-2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $33.85 | 2023-2025 | Anzupgo, Adbry |
| Sun Pharmaceutical Industries INC. | $29.33 | 2023 | Ilumya |
| Journey Medical Corporation | $28.99 | 2022-2023 | |
| Epi Health, LLC | $22.94 | 2022 | |
| Biofrontera INC. | $20.03 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $18.71 | 2025 | Exparel |
| Regeneron Healthcare Solutions, INC. | $17.85 | 2025 | Dupixent |
| Janssen Pharmaceuticals, INC | $15.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mirtha Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.